Target Name: ZFR2
NCBI ID: G23217
Review Report on ZFR2 Target / Biomarker Content of Review Report on ZFR2 Target / Biomarker
ZFR2
Other Name(s): ZFR2_HUMAN | ZFR2 variant 1 | Zinc finger RNA binding protein 2, transcript variant 1 | Zinc finger RNA-binding protein 2 | Zinc finger RNA-binding protein 2 (isoform 1) | zinc finger RNA binding protein 2 | KIAA1086

ZFR2: A Potential Drug Target for Various Diseases

ZFR2 (Zinc Finger RNA-Binding Protein 2) is a protein that is expressed in various tissues of the human body, including the brain, heart, liver, and kidney. It is a member of the RNA-binding protein family and is known for its ability to bind to specific RNA molecules with high affinity. ZFR2 has been shown to play a role in the regulation of various cellular processes, including cell growth, apoptosis, and inflammation.

One of the unique features of ZFR2 is its ability to form a stable complex with small RNA molecules, such as microRNAs and small nuclear RNAs (snRNAs). These small RNA molecules are important for various cellular processes, including gene regulation, metabolism, and stress response. ZFR2 has been shown to play a role in the formation of these small RNA molecules, which may be important for its function as a drug target.

In recent years, ZFR2 has been identified as a potential drug target for various diseases, including cancer, neurodegenerative diseases, and autoimmune diseases. ZFR2 has been shown to be involved in the regulation of various cellular processes that are implicated in the development and progression of these diseases. For example, ZFR2 has been shown to be involved in the regulation of apoptosis, which is a critical process that helps the body eliminate damaged or dysfunctional cells.

In addition to its role in apoptosis, ZFR2 has also been shown to be involved in the regulation of cell growth and metabolism. It has been shown to play a role in the regulation of cell proliferation and cell differentiation, as well as in the regulation of metabolism and energy homeostasis. These processes are important for the development and maintenance of tissues and organs, and may be implicated in the development of various diseases.

Another potential mechanism by which ZFR2 may be involved in the development and progression of diseases is its role in inflammation. ZFR2 has been shown to play a role in the regulation of inflammatory responses, and has been shown to be involved in the regulation of pro-inflammatory cytokines. These cytokines can contribute to the development and progression of inflammatory diseases, including autoimmune diseases and chronic inflammatory disorders.

In conclusion, ZFR2 is a protein that has been shown to play a role in various cellular processes that are important for the development and maintenance of tissues and organs. Its unique ability to form a stable complex with small RNA molecules makes it an attractive target for drug development, particularly for the treatment of diseases associated with the regulation of small RNA molecules, including cancer, neurodegenerative diseases, and autoimmune diseases. Further research is needed to fully understand the role of ZFR2 in these diseases and to develop effective treatments.

Protein Name: Zinc Finger RNA Binding Protein 2

The "ZFR2 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ZFR2 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

ZFTA | ZFTRAF1 | ZFX | ZFX-AS1 | ZFY | ZFYVE1 | ZFYVE16 | ZFYVE19 | ZFYVE21 | ZFYVE26 | ZFYVE27 | ZFYVE28 | ZFYVE9 | ZFYVE9P1 | ZG16 | ZG16B | ZGLP1 | ZGPAT | ZGRF1 | ZHX1 | ZHX1-C8orf76 | ZHX2 | ZHX3 | ZIC1 | ZIC2 | ZIC3 | ZIC4 | ZIC5 | ZIK1 | ZIM2 | ZIM3 | Zinc finger protein GLI | ZKSCAN1 | ZKSCAN2 | ZKSCAN3 | ZKSCAN4 | ZKSCAN5 | ZKSCAN7 | ZKSCAN8 | ZKSCAN8P1 | ZMAT1 | ZMAT2 | ZMAT3 | ZMAT4 | ZMAT5 | ZMIZ1 | ZMIZ1-AS1 | ZMIZ2 | ZMPSTE24 | ZMYM1 | ZMYM2 | ZMYM3 | ZMYM4 | ZMYM4-AS1 | ZMYM5 | ZMYM6 | ZMYND10 | ZMYND11 | ZMYND12 | ZMYND15 | ZMYND19 | ZMYND8 | ZNF10 | ZNF100 | ZNF101 | ZNF106 | ZNF107 | ZNF112 | ZNF114 | ZNF117 | ZNF12 | ZNF121 | ZNF124 | ZNF131 | ZNF132 | ZNF133 | ZNF134 | ZNF135 | ZNF136 | ZNF137P | ZNF138 | ZNF14 | ZNF140 | ZNF141 | ZNF142 | ZNF143 | ZNF146 | ZNF148 | ZNF154 | ZNF155 | ZNF157 | ZNF16 | ZNF160 | ZNF165 | ZNF169 | ZNF17 | ZNF174 | ZNF175 | ZNF177 | ZNF18